留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

应中央军委要求,2022年9月起,《药学实践杂志》将更名为《药学实践与服务》,双月刊,正文96页;2023年1月起,拟出版月刊,正文64页,数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿!

核辐射事故伤药物防治研究进展

刘玉明 张术 储智勇

刘玉明, 张术, 储智勇. 核辐射事故伤药物防治研究进展[J]. 药学实践与服务, 2011, 29(5): 321-323,346.
引用本文: 刘玉明, 张术, 储智勇. 核辐射事故伤药物防治研究进展[J]. 药学实践与服务, 2011, 29(5): 321-323,346.
LIU Yu-ming, ZHANG Shu, CHU Zhi-yong. Advances on the medication of nuclear Radiation Accidents[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(5): 321-323,346.
Citation: LIU Yu-ming, ZHANG Shu, CHU Zhi-yong. Advances on the medication of nuclear Radiation Accidents[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(5): 321-323,346.

核辐射事故伤药物防治研究进展

Advances on the medication of nuclear Radiation Accidents

  • 摘要: 随着世界各国核军备竞争的加剧,随着世界核安全形势的紧张以及核技术研究手段的不断兴起,核辐射对人类造成了极大的恐慌和伤害。如何加强核事故和核辐射损伤的应急防护和医学救治,这已经引起人们的高度重视和关注。本文针对核辐射的临床表现,从综合治疗、细胞因子、氨巯基化合物、中草药四方面,综述了目前在核事故及核辐射中药物预防与救治的研究进展,并对今后如何深入对核辐射防治药物进行开发利用进行了展望。
  • [1] Fliedner TM,Graessle D,Meineke V,et al.Pathophysiological principles underlying the blood cell concentration responses used to assess the severity of efect after accidental whole body radiation exposure:an essential basis for an evidence.based clinical triage[J].Exp Hematol,2007,35(4 Suppl 1):8.
    [2] Heimers A,Brede HJ,Giesen U,et al.Chromosome aberration analysis and the influence of mitotic delay after simulated partial-body exposure with hi gh doses uf sparsely and densely ionizing radiation[J].Radiat Environ Biophys,2006,45(1):45.
    [3] Hande MP,Azizuva TV,Burak LE,et al.Complex chromosome aberrations persist in individuals man y years after occupational exposure to densely ionizing radiation:an mF1SH study[J].Genes Chromosomes Cancer,2005,44(1):1.
    [4] Wang Y,Schulte BA,Zhou D.Hematopoietic stem cell senescence and long-term bone marrow injury[J].Cell Cycle,2006,5(1):35.
    [5] Wang Y,Schulte BA,LaRue AC,et al.Total body irradiation selectively induces murine hematopoietic stem cell senescence[J].Blood, 2006.107(1):358.
    [6] Liu YJ,Lu SH,Xu B,et al. Hemangiopoietin,a novel human growth factor for the primitive cells of both hematopoietic and endothelial cell lineages[J].Blood,2004,103(12):4449.
    [7] Herodin F,Drouet M.Cytokine-based treatment of accidentally irradiated victims and new approaches[J].Exp Hematol,2005,33(10),1071.
    [8] Hosseinimehr SJ, Zakaryaee V, Frouhgizaden M. Oral oxymetholone reduces mortality induced by gamma irradiation in mice through stimulation of hematopoietic cells[J]. Mol Cell Biochem,2006,287:193.
    [9] Drouet M,Mourcin F,Grenier N,et al.Single administration of stemcell factor.FL -3 ligand.megakaryocyte growth and developmentfactor.and interleukin-3 in combination soon after irradiationprevents nonhuman primates from myelosuppression:long-term follow-up of hematopoiesis[J].Blood,2004,103(3):878.
    [10] Demirel C, Kilciksiz S, Ay OI,et al. Effect of N-acetylcysteine on radiation-induced genotoxicity and cytotoxicity in rat bone marrow[J]. Journal-of-radiation-research,2009,50(1): 43.
    [11] Demirel C, Kilciksiz S,Evirgen S,et al. The preventive effect of N-acetylcysteine on radiation-induced dermatitis in a rat model[J]. J-BUON. 2010 ,15(3): 577.
    [12] Murley J S, Kataoka Y,Baker KL,et al. Manganese superoxide dismutase (SOD2)-mediated delayed radioprotection induced by the free thiol form of amifostine and tumor necrosis factor alpha[J]. Radiation-research,2007 ,167(4): 465.
    [13] You WC, Lin WC, Huang JT ,et al.Indigowood root extract protects hematopoietic cells reduces tissue damage and modulates inflammatory cytokines after total-body irradiation: does Indirubin play a role in radioprotection[J]. Phytomedicine,2009 ,16(12): 1105.
    [14] Liu WC, Wang SC,Tsai ML, et al.Protection against radiation-induced bone marrow and intestinal injuries by Cordyceps sinensis, a Chinese herbal medicine[J]. Radiat-Res, 2006 , 166(6): 900.
    [15] 陆兴熠 ,刘剑英,钟进义. 葡多酚对核辐射接触人员氧化损伤防护作用[J]. 中国公共卫生,2008,24(9):1072.
    [16] Goel HC, Bala M, Prasad J,et al,Radioprotection by Rhodiola imbricate in mice against whole-body lethal irradiation[J]. J Med Food. 2006 , 9(2): 154.
    [17] 梁 莉,王 婷,乔 华,等.南沙参多糖的药理作用研究进展[J]. 西北药学杂志,2008,(23) 5:334.
    [18] Li Z,Wenyi Z,Liang'an Z. General situation of radiation accidents in China[J]. Radiat Prot Dosimety,2007,124(2):177.
    [19] Weisdorf D,ChaoN,Waelenko JK,et al.Acute radiation injury:contingency planning for triage,supportive care,and transplantation[J]. Biol Blood Marrow Transplant, 2006,12(6):672.
    [20] Rencova J, Vlkova A, Vesela G. Improved chelation therapy of intramuscularly deposited horium by CaDTPA in the rat [J]. Radiat Prot Dosim, 2003, 105 : 513.
    [21] Martinez AB, Mandalunis PM, Bozal CB, et al. Renal function in mice poisoned with oral uranium and treated with ethane-1-hydroxy-1, 1-bisphosphonate ( EHBP) [J]. Health Phys, 2003, 85(3):343.
    [22] Benkovic V, Knezevic AH, Dikic D, et al. Radioprotective effects of quercetin and ethanolic extract of propolis in gamma-irradiated mice[J]. Arh Hig Rada Toksikol, 2009 , 60(2): 129.
    [23] Srinivasan M, Devipriya N, Kalpana KB, et al. Lycopene: An antioxidant and radioprotector against gamma-radiation-induced cellular damages in cultured human lymphocytes[J]. Toxicology, 2009, 262(1): 43.
    [24] Goel A, Aggarwal BB. Curcumin the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs[J]. Nutr Cancer, 2010, 62(7): 919.
  • [1] 姚一青, 方家豪, 马荟琳, 王璇, 吕狄亚.  抗辐射天然产物研究进展 . 药学实践与服务, 2022, 40(5): 427-432. doi: 10.12206/j.issn.2097-2024.202101033
    [2] 王静, 章越凡, 李铁军.  辐射防护相关信号通路研究现状 . 药学实践与服务, 2017, 35(1): 8-11. doi: 10.3969/j.issn.1006-0111.2017.01.003
    [3] 杨宏, 倪敏, 赵心彬, 陶霞.  辐射致组织损伤凋亡机制的研究概况 . 药学实践与服务, 2014, 32(2): 96-97,149. doi: 10.3969/j.issn.1006-0111.2014.02.005
    [4] 徐岩成, 方一杰, 阎澜, 姜远英, 曹永兵.  降脂药物的肝脏毒性及其防治策略研究进展 . 药学实践与服务, 2014, 32(6): 412-415,464. doi: 10.3969/j.issn.1006-0111.2014.06.004
    [5] 王庆宾, 韩婷, 孙连娜, 尚雯.  抗辐射的天然药物研究进展 . 药学实践与服务, 2012, 30(3): 171-174,177. doi: 10.3969/j.issn.1006-0111.2012.03.005
    [6] 张佳音, 舒丽芯, 陈盛新, 栾潇潇, 田甜.  核辐射伤防治药品的信息熵储备模型研究 . 药学实践与服务, 2008, (2): 120-122.
    [7] 邬蓉, 高守红, 辛海量.  人参抗辐射损伤研究概况 . 药学实践与服务, 2007, (6): 364-366,392.
    [8] 陈巧玲, 蔡宝祥.  他汀类药物防治动脉粥样硬化作用研究进展 . 药学实践与服务, 2006, (6): 321-324.
    [9] 蒯丽萍, 顾文华, 陈静.  FDA防治吸入性炭疽病的抗微生物药物研发指南 . 药学实践与服务, 2004, (5): 305-307.
    [10] 戴德银, 赵俊, 卢海波, 王萍.  浅析目前抗“非典”的药物 . 药学实践与服务, 2003, (5): 271-274.
    [11] 王文俭, 蒋雪涛, 郭涛, 董志超.  辐射法制备喃氟啶植入剂的家兔药物动力学 . 药学实践与服务, 2000, (1): 19-21.
    [12] 于天杰, 赵国景, 冀建明.  偏头痛的发病及药物防治进展 . 药学实践与服务, 1997, (1): 10-12.
    [13] 王昱, 王子立, 周丽芳.  中药在防治辐射损伤中的应用 . 药学实践与服务, 1996, (5): 317-319.
    [14] 路绪文, 高明全.  八起药疗事故应吸取的教训 . 药学实践与服务, 1995, (2): 123-124.
    [15] 黄循裕.  一起药疗事故分析 . 药学实践与服务, 1992, (2): 20-20.
    [16] 何廉卿.  临床药物不良反应及其防治 . 药学实践与服务, 1991, (4): 48-50.
    [17] 吴健, 杨爱梅.  防治褥疮液治疗褥疮51例 . 药学实践与服务, 1989, (1): 36-37.
    [18] 陈崇尚.  抗辐射中药"益康片"通过鉴定 . 药学实践与服务, 1988, (2): 85-85.
    [19] 黄榜祖, 贺逢鸣.  药疗事故纪实 . 药学实践与服务, 1988, (2): 28-29.
    [20] 陆晓和.  西米替丁的不良反应及其防治 . 药学实践与服务, 1986, (4): 34-36.
  • 加载中
计量
  • 文章访问数:  2136
  • HTML全文浏览量:  217
  • PDF下载量:  449
  • 被引次数: 0
出版历程
  • 收稿日期:  2010-11-15
  • 修回日期:  2011-04-19

核辐射事故伤药物防治研究进展

摘要: 随着世界各国核军备竞争的加剧,随着世界核安全形势的紧张以及核技术研究手段的不断兴起,核辐射对人类造成了极大的恐慌和伤害。如何加强核事故和核辐射损伤的应急防护和医学救治,这已经引起人们的高度重视和关注。本文针对核辐射的临床表现,从综合治疗、细胞因子、氨巯基化合物、中草药四方面,综述了目前在核事故及核辐射中药物预防与救治的研究进展,并对今后如何深入对核辐射防治药物进行开发利用进行了展望。

English Abstract

刘玉明, 张术, 储智勇. 核辐射事故伤药物防治研究进展[J]. 药学实践与服务, 2011, 29(5): 321-323,346.
引用本文: 刘玉明, 张术, 储智勇. 核辐射事故伤药物防治研究进展[J]. 药学实践与服务, 2011, 29(5): 321-323,346.
LIU Yu-ming, ZHANG Shu, CHU Zhi-yong. Advances on the medication of nuclear Radiation Accidents[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(5): 321-323,346.
Citation: LIU Yu-ming, ZHANG Shu, CHU Zhi-yong. Advances on the medication of nuclear Radiation Accidents[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(5): 321-323,346.
参考文献 (24)

目录

    /

    返回文章
    返回